Though associative, these findings suggest that progesterone and estrogen are part of an endogenous protective mechanism in MS and that females harness progesterone to mediate this protection, whereas males harness ER signalling, which may be less effective in inhibiting inflammation as evidenced by the higher expression of TNF (153). The gene discussed is TNF; the disease is myeloid sarcoma.